Protein- and lipid modification of natural bovine surfactant: Effects in experimental lung failure with special consideration of the response in neonates

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 1, 2006, Pages 25-32

  Gortner, Ludwig ^a   Maroske, Wiebke ^b   Reiss, Irwin ^c   Weller, Eberhard ^d  

^a SAARLAND UNIVERSITY   (Germany)

^b Red Cross Hospital   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Alveofact ; Lung failure, experimental, rat; Surfactant, effects in lung lavage model, modified, natural

Indexed keywords

BERACTANT; CORTICOSTEROID; DICHLOROMETHANE; LUNG SURFACTANT; MERCAPTOETHANOL; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; PLASMALOGEN; SPHINGOMYELIN; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CONTROLLED STUDY; LUNG GAS EXCHANGE; LUNG LAVAGE; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PROTEIN MODIFICATION; RAT; TIDAL VOLUME; VACUUM EXTRACTION;

EID: 31444456204     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296697     Document Type: Article

References (42)

1. Ainsworth, S. B., Milligan, D. W., Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review. Am. J. Respir. Med. 1, 417 (2002)
2. Soll, R. F., Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst. Rev. 2, CDOOO511 (2000)
3. Kuint, J., Reichmann, B., Neumann, L. et al., Prognostic value of the immediate response to surfactant. Arch. Dis. Child Fetal Neonatal Ed. 71, F 170 (1994)
4. Jobe, A., Protein leaks and surfactant dysfunction in the pathogenesis of respiratory [1] distress syndrome. Eur. Respir. J. 3 (Suppl.), 27 (1989)
5. Seeger, W., Stohr, G., Wolf, H. R. et al., Alteration of surfactant function due to protein leakage: spezial interaction with fibrin monomer. J. Appl. Physiol. 58, 326 (1985)
6. Holm, B. A., Notter, R. H., Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J. Appl. Physiol. 63, 1434 (1987)
7. Bummer, P. M., Sanders, L. P., Pauly, T. H. et al., In vitro inactivation of pulmonary surfactant replacement preparations by serum albumin. Am. J. Med. Sci. 307, 401 (1994)
8. Albertson, T. E., Marelich, G. P., Pharmacologic adjuncts to mechanical ventilation in acute respiratory distress syndrome. Grit. Care Clin. 14, 581 (1998)
9. Mizuno, K., Ikegami, M., Chen, C. M. et al., Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant. Pediatr. Res. 37, 271 (1995)
10. Sun, B., Curstedt, T., Lindgren, G. et al., Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur. Respir. J. 10, 1967 (1997)
11. Robertson, B., Surfactant inactivation and surfactant replacement in experimental models of ARDS. Acta Anaesthesiol. Scand. 95 (Suppl.), 22 (1991)
12. Cochrane, C. G., Revak, S. D., Merritt, T. A. et al., Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr. Res. 44, 705 (1998)
13. Reiss, I., Hilgendorff, A., Ebsen, M. et al., Comparison of recombinant SP-C and natural bovine surfactant in premature rabbits with RDS. Pediatr. Res. 54, A 573 (2003)
14. Gortner, L., Bartmann, P., Pohlandt, F. et al., Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Pediatr. Pulmonol. 14, 4 (1991)
15. Moller, J. C., Schaible, T., Roll, C. et al., Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 29, 437 (2003)
16. Lachmann, B., Robertson, B., Vogel, J., In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol. Scand. 24, 231 (1980)
17. Lachmann, B., Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome. Eur. Respir. J. 3 (Suppl.), 98 (1989)
18. Gortner, L., Pohlandt, E, Disse, B. et al., Effects of bovine surfactant in premature lambs after intra-tracheal application. Eur. J. Pediatr. 149, 280 (1990)
19. Hallman, M., Glumoff, V., Ramet, M., Surfactant in respiratory distress syndrome and lung injury. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129, 287 (2001)
20. Wyncoll, D. L., Evans, T. W., Acute respiratory distress syndrome. Lancet 354, 497 (1999)
21. Herting, E., Rauprich, P., Stichtenoth, G. et al., Resistance of different surfactant preparations to inactivation by meconium. Pediatr. Res. 50, 44 (2001)
22. Hafner, D., Beume, R., Kilian, U. et al., Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS) Br. J. Pharmacol. 115, 451 (1995)
23. Ma, J., Koppenol, S., Yu, H. et al., Effects of a cationic and hydrophobic peptide, KL4, on model lung surfactant lipid monolayers. Biophys. J. 74, 1899 (1998)
24. Walther, F. J., Hernandez-Juviel, J., Bruni, R. et al., Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats. Am. J. Respir. Crit. Care Med. 156, 855 (1997)
25. Hilgendorff, A., Rawer, D., Doerner, M. et al., Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration. Intensive Care Med. 29, 2247 (2003)
26. Hafner, D., Germann, P. G., Hauschke, D., Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Br. J. Pharmacol. 124, 1083 (1998)
27. Mbagwu, N., Bruni, R., Hernandez-Juviel, J. M. et al., Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits. Mol. Genet. Metab. 66, 40 (1999)
28. Revak, S. D., Merritt, T. A., Cochrane, C. G. et al., Efficacy of synthetic peptide- containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr. Res. 39, 715 (1996)
29. Gortner, L., Hilgendorff, A., Surfactant-associated proteins B and C: molecular biology and physiologic properties. Z. Geburtshilfe Neonatol. 208, 91 (2004)
30. Whitsett, J. A., Weaver, T. E., Hydrophobic surfactant proteins in lung function and disease. N. Engl. Med. 347, 2141 (2002)
31. Weaver, T. E., Conkright, J. J., Function of surfactant proteins B and C. Annu. Rev. Physiol. 63, 555 (2001)
32. Tsao, F. H., Zachman, R. D., Use of quantitative amniotic fluid phosphatidylglycerol as a criterion for fetal lung maturation. Am. J. Perinatol. 9, 34 (1992)
33. Seeger, W., Grube, C., Gunter, A., Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J. 6, 971 (1993)
34. Rebello, C. M., Ikegami, M., Polk, D. H. et al., Postnatal lung responses and surfactant function after fetal or maternal corticosteroid treatment. J. Appl. Physiol. 80, 1674 (1996)
35. Kari, M. A., Hallman, M., Eronen, M. et al., Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 93, 730 (1994)
36. Strohmaier, W., Schlag, G., Experimental aspiration trauma: comparison of steroid treatment versus exogenous natural surfactant. Exp. Lung Res. 19, 397 (1993)
37. Adhikari, N., Burns, K., Meade, M., Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst. Rev. 18, CD004477 (2004)
38. Grier, D. G., Halliday, H. L., Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Semin. Neonatol. 8, 83 (2003)
39. Meltzer, E. O., Kemp, J. P., Orgel, H. A. et al., Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children. Pediatrics 69, 340 (1982)
40. Gortner, L., Pohlandt, F., Bartmann, P. et al., High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr. 83, 135 (1994)
41. Crowley, P., Prophylactic corticosteroids for preterm birth. Cochrane Database Syst. Rev. 2, CD000065 (2000)
42. Ballabh, P., Simm, M., Kumari, J. et al., Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids. Arch. Dis. Child Fetal Neonatal. 89, F76 (2004)